{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:24:04Z","timestamp":1764689044023},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1014-9","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T16:03:02Z","timestamp":1436803382000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Seung Beom","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong koo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Seo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nack-Gyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Chul","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Han","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hack-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Sil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Ah","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s12185-008-0184-2","volume":"88","author":"J Auberger","year":"2008","unstructured":"Auberger J, Lass-Florl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, et al. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2008;88:508\u201315.","journal-title":"Int J Hematol"},{"key":"1014_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091\u2013100.","journal-title":"Clin Infect Dis"},{"key":"1014_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/pbc.21868","volume":"52","author":"Z Kaya","year":"2009","unstructured":"Kaya Z, Gursel T, Kocak U, Aral YZ, Kalkanci A, Albayrak M. Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis. Pediatr Blood Cancer. 2009;52:470\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"1014_CR4","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/MPH.0b013e3181acd956","volume":"31","author":"PM Rubio","year":"2009","unstructured":"Rubio PM, Sevilla J, Gonzalez-Vicent M, Lassaletta A, Cuenca-Estrella M, D\u00edaz MA, et al. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study. J Pediatr Hematol Oncol. 2009;31:642\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1014_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/s-0032-1304625","volume":"224","author":"F Babor","year":"2012","unstructured":"Babor F, Schuster F, Mackenzie C, Meisel R, Schaper J, Sabir H, et al. Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis-case analysis to plan better targeted prophylactic or therapeutic measurement. Klin Padiatr. 2012;224:160\u20135.","journal-title":"Klin Padiatr"},{"key":"1014_CR6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","volume":"96","author":"M Kurosawa","year":"2012","unstructured":"Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, et al. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2012;96:748\u201357.","journal-title":"Int J Hematol"},{"key":"1014_CR7","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/pbc.23005","volume":"56","author":"M Mor","year":"2011","unstructured":"Mor M, Gilad G, Kornreich L, Fisher S, Yaniv I, Levy I. Invasive fungal infections in pediatric oncology. Pediatr Blood Cancer. 2011;56:1092\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"1014_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408\u201315.","journal-title":"N Engl J Med"},{"key":"1014_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/595846","volume":"48","author":"D Neofytos","year":"2009","unstructured":"Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009;48:265\u201373.","journal-title":"Clin Infect Dis"},{"key":"1014_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","volume":"65","author":"WJ Steinbach","year":"2012","unstructured":"Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect. 2012;65:453\u201364.","journal-title":"J Infect"},{"key":"1014_CR11","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"1014_CR12","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","volume":"15","author":"AH Groll","year":"2014","unstructured":"Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014;15:e327\u201340.","journal-title":"Lancet Oncol"},{"key":"1014_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/503427","volume":"42","author":"CD Pfeiffer","year":"2006","unstructured":"Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42:1417\u201327.","journal-title":"Clin Infect Dis"},{"key":"1014_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1439-0507.2010.02009.x","volume":"54","author":"SH Park","year":"2011","unstructured":"Park SH, Choi SM, Lee DG, Choi JH, Kim SH, Kwon JC, et al. Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients. Mycoses. 2011;54:523\u201330.","journal-title":"Mycoses"},{"key":"1014_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/cncr.24022","volume":"115","author":"J Maertens","year":"2009","unstructured":"Maertens J, Buve K, Theunissen K, Meersseman W, Verbeken E, Verhoef G, et al. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer. 2009;115:355\u201362.","journal-title":"Cancer"},{"key":"1014_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/cncr.22863","volume":"110","author":"G Woods","year":"2007","unstructured":"Woods G, Miceli MH, Grazziutti ML, Zhao W, Barlogie B, Anaissie E. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer. 2007;110:830\u20134.","journal-title":"Cancer"},{"key":"1014_CR17","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1086\/528714","volume":"46","author":"MH Miceli","year":"2008","unstructured":"Miceli MH, Grazziutti ML, Woods G, Zhao W, Kocoglu MH, Barlogie B, et al. Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis. 2008;46:1412\u201322.","journal-title":"Clin Infect Dis"},{"key":"1014_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1128\/JCM.00750-11","volume":"50","author":"A Bergeron","year":"2012","unstructured":"Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, et al. Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. J Clin Microbiol. 2012;50:823\u201330.","journal-title":"J Clin Microbiol"},{"key":"1014_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1086\/339324","volume":"34","author":"F Boutboul","year":"2002","unstructured":"Boutboul F, Alberti C, Leblanc T, Sulahian A, Gluckman E, Derouin F, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis. 2002;34:939\u201343.","journal-title":"Clin Infect Dis"},{"key":"1014_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.patbio.2011.10.011","volume":"60","author":"I Hadrich","year":"2012","unstructured":"Hadrich I, Makni F, Cheikhrouhou F, Neji S, Amouri I, Sellami H, et al. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis. Pathol Biol. 2012;60:357\u201361.","journal-title":"Pathol Biol"},{"key":"1014_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00006454-199603000-00011","volume":"15","author":"P Rohrlich","year":"1996","unstructured":"Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint-Martin C, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J. 1996;15:232\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"1014_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1086\/590566","volume":"47","author":"BH Segal","year":"2008","unstructured":"Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47:674\u201383.","journal-title":"Clin Infect Dis"},{"key":"1014_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3904\/kjim.2011.26.2.220","volume":"26","author":"DG Lee","year":"2011","unstructured":"Lee DG, Kim SH, Kim SY, Kim CJ, Park WB, Song YG, et al. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med. 2011;26:220\u201352.","journal-title":"Korean J Intern Med"},{"key":"1014_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3947\/ic.2012.44.4.282","volume":"44","author":"SH Kim","year":"2012","unstructured":"Kim SH, Moon SM, Han SH, Chung JW, Moon SY, Lee MS, et al. Epidemiology and clinical outcomes of Invasive Pulmonary Aspergillosis: a nationwide multicenter study in Korea. Infect Chemother. 2012;44:282\u20138.","journal-title":"Infect Chemother"},{"key":"1014_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/pbc.24363","volume":"60","author":"SH Choi","year":"2013","unstructured":"Choi SH, Kang ES, Eo H, Yoo SY, Kim JH, Yoo KH, et al. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients. Pediatr Blood Cancer. 2013;60:316\u201322.","journal-title":"Pediatr Blood Cancer"},{"key":"1014_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4046\/trd.2012.72.3.284","volume":"72","author":"JC Kwon","year":"2012","unstructured":"Kwon JC, Kim SH, Park SH, Choi SM, Lee DG, Choi JH, et al. Prognosis of invasive pulmonary aspergillosis in patients with hematologic diseases in Korea. Tuberc Respir Dis. 2012;72:284\u201392.","journal-title":"Tuberc Respir Dis"},{"key":"1014_CR27","doi-asserted-by":"publisher","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","volume":"121","author":"A Burgos","year":"2008","unstructured":"Burgos A, Zaoutis TE, Dvorak CC, Hoffman JA, Knapp KM, Nania JJ, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics. 2008;121:e1286\u201394.","journal-title":"Pediatrics"},{"key":"1014_CR28","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1086\/592255","volume":"47","author":"Y Nivoix","year":"2008","unstructured":"Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Am\u00e9 S, Fohrer C, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis. 2008;47:1176\u201384.","journal-title":"Clin Infect Dis"},{"key":"1014_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/509917","volume":"44","author":"RE Greene","year":"2007","unstructured":"Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44:373\u20139.","journal-title":"Clin Infect Dis"},{"key":"1014_CR30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","volume":"19","author":"D Caillot","year":"2001","unstructured":"Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol. 2001;19:253\u20139.","journal-title":"J Clin Oncol"},{"key":"1014_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2214\/ajr.150.5.1015","volume":"150","author":"JE Kuhlman","year":"1988","unstructured":"Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. CT of invasive pulmonary aspergillosis. AJR Am J Roentgenol. 1988;150:1015\u201320.","journal-title":"AJR Am J Roentgenol"},{"key":"1014_CR32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/cid\/cit393","volume":"57","author":"CE Fisher","year":"2013","unstructured":"Fisher CE, Stevens AM, Leisenring W, Pergam SA, Boeckh M, Hohl TM. The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis. Clin Infect Dis. 2013;57:1001\u20134.","journal-title":"Clin Infect Dis"},{"key":"1014_CR33","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1128\/JCM.02281-09","volume":"48","author":"S Koo","year":"2010","unstructured":"Koo S, Bryar JM, Baden LR, Marty FM. Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol. 2010;48:1255\u201360.","journal-title":"J Clin Microbiol"},{"key":"1014_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jac\/dkg367","volume":"52","author":"MJ Becker","year":"2003","unstructured":"Becker MJ, de Marie S, Fens MH, Verbrugh HA, Bakker-Woudenberg IA. Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis. J Antimicrob Chemother. 2003;52:428\u201334.","journal-title":"J Antimicrob Chemother"},{"key":"1014_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1128\/AAC.45.3.857-869.2001","volume":"45","author":"R Petraitiene","year":"2001","unstructured":"Petraitiene R, Petraitis V, Groll AH, Sein T, Piscitelli S, Candelario M, et al. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother. 2001;45:857\u201369.","journal-title":"Antimicrob Agents Chemother"},{"key":"1014_CR36","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1128\/AAC.00276-08","volume":"52","author":"AC Vallor","year":"2008","unstructured":"Vallor AC, Kirkpatrick WR, Najvar LK, Bocanegra R, Kinney MC, Fothergill AW, et al. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother. 2008;52:2593\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1014_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327\u201360.","journal-title":"Clin Infect Dis"},{"key":"1014_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1586\/eri.13.29","volume":"11","author":"N Hatipoglu","year":"2013","unstructured":"Hatipoglu N, Hatipoglu H. Combination antifungal therapy for invasive fungal infections in children and adults. Expert Rev Anti Infect Ther. 2013;11:523\u201335.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1014_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/M13-2508","volume":"162","author":"KA Marr","year":"2015","unstructured":"Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015;162:81\u20139.","journal-title":"Ann Intern Med"},{"key":"1014_CR40","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/cncr.23109","volume":"110","author":"D Caillot","year":"2007","unstructured":"Caillot D, Thiebaut A, Herbrecht R, de Botton S, Pigneux A, Bernard F, et al. Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial). Cancer. 2007;110:2740\u20136.","journal-title":"Cancer"},{"key":"1014_CR41","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1086\/514341","volume":"44","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44:1289\u201397.","journal-title":"Clin Infect Dis"},{"key":"1014_CR42","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1586\/14787210.2013.826989","volume":"11","author":"S Seyedmousavi","year":"2013","unstructured":"Seyedmousavi S, Mouton JW, Verweij PE, Bruggemann RJ. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis. Expert Rev Anti Infect Ther. 2013;11:931\u201341.","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1014-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1014-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T17:00:37Z","timestamp":1630602037000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1014-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1014-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]},"assertion":[{"value":"25 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"271"}}